FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Guanfacine Hydrochloride Tablets
Status: Currently in Shortage
»Date first posted: 10/24/2017
»Therapeutic Categories: Cardiovascular

Expand all

Amneal Pharmaceutical (Revised 01/24/2018)

Company Contact Information:
877-835-5472

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg bottles of 30 (NDC 65162-711-03); 1 mg bottles of 100 (NDC 65162-711-10) Available Other
2 mg bottles of 30 (NDC 65162-713-03); 2 mg bottles of 100 (NDC 65162-713-10); 2 mg bottles of 500 (NDC 65162-713-50) Available Other

Mylan Pharmaceuticals Inc. (Reverified 10/09/2018)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg (NDC 0378-1160-01) Unavailable. Estimated recovery: Q1-2019 Other
2 mg (NDC 0378-1190-01) Unavailable. Estimated recovery: Q1-2019 Other

Teva Pharmaceuticals (Revised 10/11/2018)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1mg tablets 100 count bottle (NDC 0591-0444-01) Allocating inventory - expected resupply late November. Demand increase for the drug
2 mg tablets 100 count bottle (NDC 0591-0453-01) Allocating inventory - expected resupply December. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English